Neurocognitive individualized training versus social skills individualized training: A randomized trial in patients with schizophrenia

Schizophrenia Research

Volumn 150, Issue 1, 2013, Pages 69-75

  Bucci, Paola ^a   Piegari, Giuseppe ^a   Mucci, Armida ^a   Merlotti, Eleonora ^a   Chieffi, Marcello ^a   De Riso, Francesco ^a   De Angelis, Maria ^b   Di Munzio, Walter ^b   Galderisi, Silvana ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Azienda Sanitaria di Salerno   (Italy)

Author keywords

Cognitive training; Individualized interventions; Real world functioning; Social skills training

Indexed keywords

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; CONTROLLED STUDY; DEPTH PERCEPTION; EXECUTIVE FUNCTION; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERVENTION STUDY; MALE; MENTAL DISEASE; NEUROCOGNITIVE INDIVIDUALIZED TRAINING; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSOCIAL REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOCIAL ADAPTATION; SOCIAL SKILLS INDIVIDUALIZED TRAINING; TREATMENT DURATION; VERBAL MEMORY;

COGNITIVE TRAINING; INDIVIDUALIZED INTERVENTIONS; REAL-WORLD FUNCTIONING; SOCIAL SKILLS TRAINING;

ADULT; ANALYSIS OF VARIANCE; ATTENTION; COGNITION DISORDERS; COGNITIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REALITY TESTING; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL BEHAVIOR; TIME FACTORS; VERBAL LEARNING;

EID: 84884145254     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.07.053     Document Type: Article

References (50)

1. Addington J., Addington D. Neurocognitive and social functioning in schizophrenia. Schizophr. Bull. 1999, 25(1):173-182.
2. Bark N., Revheim N., Huq F., Khalderov V., Ganz Z.W., Medalia A. The impact of cognitive remediation on psychiatric symptoms of schizophrenia. Schizophr. Res. 2003, 63(3):229-235.
3. Bellack A.S., Mueser K.T., Gingerich S., Agresta J. Social Skills Training for Schizophrenia. A step by step guide 1997, Guilford Press, New York.
4. Benton A.L., Hamsher K. Multilingual Aphasia Examination Manual (Revised) 1978, University of Iowa, Iowa City.
5. Bilder R.M., Goldman R.S., Volavka J., Czobor P., Hoptman M., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J., Kunz M., Chakos M., Cooper T.B., Horowitz T.L., Lieberman J.A. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am. J. Psychiatry 2002, 159(6):1018-1028.
6. Bowie C.R., Harvey P.D. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr. Dis. Treat. 2006, 2(4):531-536.
7. Bowie C.R., Leung W.W., Reichenberg A., McClure M.M., Patterson T.L., Heaton R.K., Harvey P.D. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol. Psychiatry 2008, 63(5):505-511.
8. Bowie C.R., McGurk S.R., Mausbach B., Patterson T.L., Harvey P.D. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. Am. J. Psychiatry 2012, 169(7):710-718.
9. Bowie C.R., Reichenberg A., Patterson T.L., Heaton R.K., Harvey P.D. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am. J. Psychiatry 2006, 163(3):418-425.
10. Buchanan R.W., Keefe R.S., Umbricht D., Green M.F., Laughren T., Marder S.R. The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5years later?. Schizophr. Bull. 2011, 37(6):1209-1217.
11. Bustillo J.R., Lauriello J., Keith S.J. Schizophrenia: improving outcome. Harv. Rev. Psychiatry 1999, 6(5):229-240.
12. Cohen A.S., Forbes C.B., Mann M.C., Blanchard J.J. Specific cognitive deficits and differential domains of social functioning impairment in schizophrenia. Schizophr. Res. 2006, 81(2-3):227-238.
13. Davidson M., Galderisi S., Weiser M., Werbeloff N., Fleischhacker W.W., Keefe R.S., Boter H., Keet I.P., Prelipceanu D., Rybakowski J.K., Libiger J., Hummer M., Dollfus S., López-Ibor J.J., Hranov L.G., Gaebel W., Peuskens J., Lindefors N., Riecher-Rössler A., Kahn R.S. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am. J. Psychiatry 2009, 166(6):675-682.
14. Diamond A. Executive functions. Annu. Rev. Psychol. 2013, 64:135-168.
15. Frangou S. Cognitive function in early onset schizophrenia: a selective review. Front. Hum. Neurosci. 2010, 3:1-6.
16. Galderisi S., Piegari G., Mucci A., Acerra A., Luciano L., Rabasca A.F., Santucci F., Valente A., Volpe M., Mastantuono P., Maj M. Social skills and neurocognitive individualized training in schizophrenia: comparison with structured leisure activities. Eur. Arch. Psychiatry Clin. Neurosci. 2010, 260(4):305-315.
17. Gharaeipour M., Scott B.J. Effects of cognitive remediation on neurocognitive functions and psychiatric symptoms in schizophrenia inpatients. Schizophr. Res. 2012, 142(1-3):165-170.
18. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 2000, 26(1):119-136.
19. Green M.F., Kern R.S., Heaton R.K. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr. Res. 2004, 72(1):41-51.
20. Grynszpan O.P., Perbal S., Pelissolo A., Fossati P., Jouvent R., Dubal S., Perez-Diaz F. Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study. Psychol. Med. 2011, 41(1):163-173.
21. Harris A.W., Williams L., Gordon E., Bahramali H., Slewa-Younan S. Different psychopathological models and quantified EEG in schizophrenia. Psychol. Med. 1999, 29(5):1175-1181.
22. Harvey P.D., Bowie C.R. Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches. Psychiatr. Clin. N. Am. 2012, 35(3):683-698.
23. Harvey P.D., Howanitz E., Parrella M., White L., Davidson M., Mohs R.C., Hoblyn J., Davis K.L. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am. J. Psychiatry 1998, 155(8):1080-1086.
24. Harvey P.D., Green M.F., McGurk S.R., Meltzer H.Y. Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology (Berl) 2003, 169(3-4):404-411.
25. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Curtiss G. Wisconsin Card Sorting Test Manual 1993, Psychological Assessment Resources, Odessa, Fla.
26. Heinrichs D.W., Hanlon T.E., Carpenter W.T. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 1984, 10(3):388-398.
27. Hogarty G.E., Flesher S., Ulrich R., Carter M., Greenwald D., Pogue-Geile M., Kechavan M., Cooley S., DiBarry A.L., Garrett A., Parepally H., Zoretich R. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch. Gen. Psychiatry 2004, 61(9):866-876.
28. Horan W.P., Kern R.S., Tripp C., Hellemann G., Wynn J.K., Bell M., Marder S.R., Green M.F. Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. J. Psychiatr. Res. 2011, 45(8):1113-1122.
29. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
30. Keefe R.S., Seidman L.J., Christensen B.K., Hamer R.M., Sharma T., Sitskoorn M.M., Lewine R.R., Yurgelun-Todd D.A., Gur R.C., Tohen M., Tollefson G.D., Sanger T.M., Lieberman J.A. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am. J. Psychiatry 2004, 161(6):985-995.
31. Kern R.S., Green M.F., Mitchell S., Kopelowicz A., Mintz J., Liberman R.P. Extensions of errorless learning for social problem-solving deficits in schizophrenia. Am. J. Psychiatry 2005, 162(3):513-519.
32. Kopelowicz A., Liberman R.P., Zarate R. Recent advances in social skills training for schizophrenia. Schizophr. Bull. 2006, 32(Suppl. 1):12-23.
33. Kurtz M.M., Mueser K.T. A meta-analysis of controlled research on social skills training for schizophrenia. J. Consult. Clin. Psychol. 2008, 76(3):491-504.
34. Kurtz M.M., Moberg P.J., Gur R.C., Gur R.E. Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis. Neuropsychol. Rev. 2001, 11(4):197-210.
35. Maj M., D'Elia L., Satz P., Janssen R., Zaudig M., Uchiyama C., Starace F., Galderisi S., Chervinsky A. Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch. Clin. Neuropsychol. 1993, 8(2):123-135.
36. McClure M.M., Bowie C.R., Patterson T.L., Heaton R.K., Weaver C., Anderson H., Harvey P.D. Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships?. Schizophr. Res. 2007, 89(1-3):330-338.
37. McGurk S.R., Twamley E.W., Sitzer D.I., McHugo G.J., Mueser K.T. A meta-analysis of cognitive remediation in schizophrenia. Am. J. Psychiatry 2007, 164(12):1791-1802.
38. Medalia A., Saperstein A.M. Does cognitive remediation for schizophrenia improve functional outcomes?. Curr. Opin. Psychiatry 2013, 26(2):151-157.
39. Mishara A.L., Goldberg T.E. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol. Psychiatry 2004, 55(10):1013-1022.
40. Reitan R.M., Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation 1993, Neuropsychology Press, Tucson. 2nd edn.
41. Rose D., Farrier D., Doran A.-M., Sporle T., Bogner D., Wykes T. What do clients think of cognitive remediation therapy: a consumer led investigation of satisfaction and side effects. Am. J. Psychiatr. Rehab. 2008, 11(2):181-204.
42. Rutschmann J., Cornblatt B., Erlenmeyer-Kimling L. Sustained attention in children at risk for schizophrenia. Report on a continuous performance test. Arch. Gen. Psychiatry 1977, 34(5):571-575.
43. Saperstein A.M., Fiszdon J.M., Bell M.D. Intrinsic motivation as a predictor of work outcome after vocational rehabilitation in schizophrenia. J. Nerv. Ment. Dis. 2011, 199(9):672-677.
44. Silverstein S.M., Wilkniss S.M. At issue: the future of cognitive rehabilitation of schizophrenia. Schizophr. Bull. 2004, 30(4):679-692.
45. Twamley E.W., Jeste D.V., Bellack A.S. A review of cognitive training in schizophrenia. Schizophr. Bull. 2003, 29(2):359-382.
46. Velligan D.I., Kern R.S., Gold J.M. Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies. Schizophr. Bull. 2006, 32(3):474-485.
47. Woodward N.D., Purdon S.E., Meltzer H.Y., Zald D.H. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int. J. Neuropsychopharmacol. 2005, 8(3):457-472.
48. Woodward N.D., Purdon S.E., Meltzer H.Y., Zald D.H. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Schizophr. Res. 2007, 89(1-3):211-224.
49. Wykes T., Spaulding W.D. Thinking about the future cognitive remediation therapy - what works and could we do better?. Schizophr. Bull. 2011, 37(Suppl. 2):80-90.
50. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatry 2011, 168(5):472-485.